The key factors driving the growth of the IVD market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries.
Browse 138 market data tables and 69 figures spread through 278 pages and in-depth TOC on “BRIC IVD Market”
https://www.marketsandmarkets.com/Market-Reports/ivd-bric-market-198.html
However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%.
This research study involved the extensive use of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.
BRIC IVD Market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The molecular diagnostics segment is estimated to register the highest CAGR during the forecast period of 2017 to 2022. The rising prevalence of infectious diseases, cancer, and various genetic disorders; growing demand for blood screening; and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing is expected to drive the growth of the market during the forecast period.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=198
The major BRIC IVD Market in the BRIC IVD Market and other emerging countries are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), QIAGEN N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
Contact Information:
Mr. Shelly Singh
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:
https://www.marketsandmarkets.com/Market-Reports/ivd-bric-market-198.html
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit